NCT05407142: An Open Comprative Study of the Prophylactic Efficacy and a Non-comparative Study of the Immunogenicity and Safety of the Inactivated Whole-virion Concentrated Purified Coronavirus Vaccine (CoviVac) |
|
|
| Recruiting | 3 | 29000 | RoW | CoviVac vaccine (inactivated whole-virion concentrated purified) manufactured by FSBSI "Chumakov FSC R&D IBP RAS", The data from volunteers from the control group | Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products | Coronavirus Infections, Vaccine | 06/23 | 12/23 | | |
